<?xml version="1.0" encoding="UTF-8"?>
<p>Of the 25 patients randomized to receive boceprevir, 11 patients (44%) achieved SVR24 and of the 25 patients randomized to telaprevir, 12 patients achieved SVR24 (48%). SVR24 rates by treatment stratification are presented in 
 <xref rid="pone.0163945.t003" ref-type="table">Table 3</xref>.
</p>
